Engineering synthetic phages against pathogenic E. coli as an innovative tool for phage therapy
Engineering synthetic phages against pathogenic E. coli as an innovative tool for phage therapy
批准号:
BB/N011872/1
负责人:
Antonia Sagona
金额:
$37.52万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2016
资助国家:
英国
项目状态:
已结题
起止时间:
2016 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SummaryA major challenge to patient safety is the hospital infections caused by Gram-negative bacteria that are resistant to antibiotics. A well-defined bacterial strain of this kind is Escherichia coli (E. coli) O18:K1:H7, which is responsible for secondary infections in burn patients, neonatal meningitis and sepsis, and acute cystitis. One of the possible solutions to this problem is the use of bacteriophages as antimicrobial agents. Bacteriophages are viruses that infect and kill bacteria. They show high specificity to their bacterial target, while having minimal side effects on the host, so they can potentially be used to treat bacterial infections in humans. However, there are still concerns for phage therapy, over the potential for immune response, rapid toxin release by the phages and difficulty of dose determination in clinical situations. Additionally, little is known about the cell biology underlying phage therapy, due to the challenges in the field, so that has been an obstacle in the rapid progress of phage therapy.The key aim of the research proposal is to engineer a model system as a tool for phage therapy consisting of 3 parts: a synthetic phage able to target a well-known pathogen, the pathogen (E.coli O18:K1:H7), and mammalian cells to test the phage-bacterium interplay mimicking the conditions of the human body. This system, with proper validation, can be used further for studies, establishing a promising proof of concept for safe phage therapy, which can treat conditions such as infection in burn wound patients, neonatal meningitis or acute cystitis, caused by the target pathogen. A combination of molecular biology, synthetic biology and microscopy methods will be enable me to achieve the objectives. The research will be undertaken in the School of Life Sciences, University of Warwick, in the lab of Professor Alfonso Jaramillo. The University of Warwick has been ranked as the 7th top institutions within the UK according to the Research Excellence Framework 2014. The School of Life Sciences was rated as world-leading (80% of its outputs were rated as world leading or internationally excellent).
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1038/s41598-018-35859-6
发表时间:
2018-12-03
期刊:
Scientific reports
影响因子:
4.6
作者:
[Møller-Olsen C, Ho SFS, Shukla RD, Feher T, Sagona AP]
通讯作者:
Sagona AP
DOI:
10.1021/acssynbio.2c00244
发表时间:
2022-10
期刊:
ACS synthetic biology
影响因子:
4.7
作者:
[Sahan B. W. Liyanagedera;Joshua Williams;Joseph P. Wheatley;A. Biketova;Muhammad Hasan;Antonia P. Sagona;K. Purdy;R. J. Puxty;T. Fehér;V. Kulkarni]
通讯作者:
Sahan B. W. Liyanagedera;Joshua Williams;Joseph P. Wheatley;A. Biketova;Muhammad Hasan;Antonia P. Sagona;K. Purdy;R. J. Puxty;T. Fehér;V. Kulkarni
DOI:
10.1021/acssynbio.3c00135
发表时间:
2023-07-21
期刊:
ACS SYNTHETIC BIOLOGY
影响因子:
4.7
作者:
[Williams, Joshua, Kerven, Jaimee, Chen, Yin, Sagona, Antonia P.]
通讯作者:
Sagona, Antonia P.
DOI:
10.3389/fcimb.2022.863712
发表时间:
2022
期刊:
Frontiers in cellular and infection microbiology
影响因子:
5.7
作者:
[]
通讯作者:
DOI:
10.3390/biology10060556
发表时间:
2021-06-20
期刊:
Biology
影响因子:
4.2
作者:
[Avramucz Á, Møller-Olsen C, Grigonyte AM, Paramalingam Y, Millard A, Sagona AP, Fehér T]
通讯作者:
Fehér T
Development of a rapid cow-side bacteriophage-based diagnostic method for the detection of Staphylococcus aureus mastitis
-
批准号:BB/V017217/1
-
项目类别:Research Grant
-
资助金额:$19.29万
-
财政年份:2021
-
负责人:Antonia Sagona
-
依托单位:
国内基金
海外基金
近空间飞行器载MIMO SAR高分辨率、宽测绘带遥感成像机理与方法
-
批准号:41101317
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2011
-
负责人:王文钦
-
依托单位:
基于大机动运动平台的特定目标多极化成像与匹配技术研究
-
批准号:11176022
-
项目类别:联合基金项目
-
资助金额:46.0万元
-
批准年份:2011
-
负责人:周峰
-
依托单位: